{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:17:08Z","timestamp":1788164228462,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173125"],"award-info":[{"award-number":["82173125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974374"],"award-info":[{"award-number":["81974374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303924"],"award-info":[{"award-number":["82303924"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-044A"],"award-info":[{"award-number":["TJYXZDXK-044A"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-058B"],"award-info":[{"award-number":["TJYXZDXK-058B"]}]},{"name":"Talent Introduction Scientific Research Start-up Fund of Shanxi Bethune Hospital","award":["2023RC03"],"award-info":[{"award-number":["2023RC03"]}]},{"name":"Fundamental Research Program of Shanxi Province","award":["202203021222349"],"award-info":[{"award-number":["202203021222349"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypoxic microenvironment is an important characteristic of solid tumors. A series of adaptations associated with hypoxia occur in cancer cells, including reprogramming of multiple metabolic pathways. Gastrointestinal bleeding is a common clinical symptom of CRC, resulting in anemia and iron deficiency. CRC patients have unbalanced iron homeostasis due to blood loss, chronic inflammation, etc. However, the molecular mechanisms underlying the effect of hypoxia-induced reprogramming of iron metabolism on chemosensitivity in CRC remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>RIP-seq combined with lncRNA-seq was conducted on hypoxia or normoxia CRC cells, to screen a profile of lncRNAs. Based on the characteristics of IRE elements, the sequence alignment and secondary structure analysis of the above screened lncRNAs were carried out by using open-access databases. Then lnc-IRP was obtained. RNA pull-down, RIP, RNA FISH and IF were used to confirm the binding and co-localization relationship between lnc-IRP and IRP2. Subsequently, the role of lnc-IRP in the chemosensitivity of CRC was verified both in vitro and in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>lnc-IRP relied on its IRE-like element to competitively bind IRP2, which disrupted intracellular iron regulatory network, leading to a tendency of iron to be stored in a ferric form rather than converted to LIP, and ultimately inhibiting apoptosis and ferroptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>lnc-IRP is a potential therapeutic target to restore iron homeostasis under hypoxia, thereby increasing the sensitivity of CRC to oxaliplatin, which is expected to provide a new choice for clinical treatment, and thus improve the prognosis of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08440-3","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:59:19Z","timestamp":1782136759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia-induced lnc-IRP drives oxaliplatin resistance in colorectal cancer through IRP2 sequestration and iron metabolism reprogramming"],"prefix":"10.1186","volume":"24","author":[{"given":"Haiou","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xipeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-3920","authenticated-orcid":false,"given":"Haiyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"8440_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8440_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021;325:669\u201385.","journal-title":"JAMA"},{"key":"8440_CR3","doi-asserted-by":"crossref","unstructured":"Morris VK, Kennedy EB, Baxter NN, Benson AB 3rd, Cercek A, Cho M, et al. Treatment of Metastatic Colorectal Cancer: ASCO Guideline. J Clin Oncol. 2023;41:678\u2013700.","DOI":"10.1200\/JCO.22.01690"},{"key":"8440_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.actbio.2023.02.012","volume":"160","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wei D, Wang B, Tang D, Cheng A, Xiao S, et al. NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death. Acta Biomater. 2023;160:198\u2013210.","journal-title":"Acta Biomater"},{"key":"8440_CR5","doi-asserted-by":"crossref","unstructured":"Li D, Kou Y, Gao Y, Liu S, Yang P, Hasegawa T, et al. Oxaliplatin induces the PARP1-mediated parthanatos in oral squamous cell carcinoma by increasing production of ROS. Aging (Albany N Y). 2021;13:4242\u201357.","DOI":"10.18632\/aging.202386"},{"key":"8440_CR6","doi-asserted-by":"publisher","first-page":"110676","DOI":"10.1016\/j.biopha.2020.110676","volume":"131","author":"D Xue","year":"2020","unstructured":"Xue D, Zhou X, Qiu J. Emerging role of NRF2 in ROS-mediated tumor chemoresistance. Biomed Pharmacother. 2020;131:110676.","journal-title":"Biomed Pharmacother"},{"key":"8440_CR7","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","volume":"268","author":"L Kang","year":"2021","unstructured":"Kang L, Tian Y, Xu S, Chen H. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment. J Neurol. 2021;268:3269\u201382.","journal-title":"J Neurol"},{"key":"8440_CR8","doi-asserted-by":"publisher","first-page":"104682","DOI":"10.1016\/j.jprot.2022.104682","volume":"266","author":"L Yang","year":"2022","unstructured":"Yang L, Wang H, Lu W, Yang G, Lin Z, Chen R, et al. Quantitative proteomic analysis of oxaliplatin induced peripheral neurotoxicity. J Proteom. 2022;266:104682.","journal-title":"J Proteom"},{"key":"8440_CR9","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1200\/JCO.23.01080","volume":"42","author":"L Chen","year":"2024","unstructured":"Chen L, Wang Y, Cai C, Ding Y, Kim RS, Lipchik C, et al. Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer. J Clin Oncol. 2024;42:1520\u201330.","journal-title":"J Clin Oncol"},{"key":"8440_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(24)00360-X","volume":"404","author":"C Eng","year":"2024","unstructured":"Eng C, Yoshino T, Ruiz-Garcia E, Mostafa N, Cann CG, O\u2019Brian B, et al. Colorectal cancer. Lancet. 2024;404:294\u2013310.","journal-title":"Lancet"},{"key":"8440_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/nutrit\/nuaa040","volume":"79","author":"O Phipps","year":"2021","unstructured":"Phipps O, Brookes MJ, Al-Hassi HO. Iron deficiency, immunology, and colorectal cancer. Nutr Rev. 2021;79:88\u201397.","journal-title":"Nutr Rev"},{"key":"8440_CR12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","volume":"82","author":"R Rodriguez","year":"2022","unstructured":"Rodriguez R, Schreiber SL, Conrad M. Persister cancer cells: Iron addiction and vulnerability to ferroptosis. Mol Cell. 2022;82:728\u201340.","journal-title":"Mol Cell"},{"key":"8440_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","volume":"38","author":"SV Torti","year":"2018","unstructured":"Torti SV, Manz DH, Paul BT, Blanchette-Farra N, Torti FM. Iron and Cancer. Annu Rev Nutr. 2018;38:97\u2013125.","journal-title":"Annu Rev Nutr"},{"key":"8440_CR14","doi-asserted-by":"crossref","unstructured":"Mizumura K, Gon Y. Iron-regulated reactive oxygen species production and programmed cell death in chronic obstructive pulmonary disease. Antioxid (Basel). 2021;10.","DOI":"10.3390\/antiox10101569"},{"key":"8440_CR15","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.bbagen.2019.06.010","volume":"1863","author":"T Nakamura","year":"2019","unstructured":"Nakamura T, Naguro I, Ichijo H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochim Biophys Acta Gen Subj. 2019;1863:1398\u2013409.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"8440_CR16","doi-asserted-by":"publisher","first-page":"eaau9940","DOI":"10.1126\/sciadv.aau9940","volume":"5","author":"A Daruich","year":"2019","unstructured":"Daruich A, Le Rouzic Q, Jonet L, Naud MC, Kowalczuk L, Pournaras JA, et al. Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection. Sci Adv. 2019;5:eaau9940.","journal-title":"Sci Adv"},{"key":"8440_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280\u201397.","journal-title":"Nat Rev Cancer"},{"key":"8440_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3324\/haematol.2019.232124","volume":"105","author":"C Camaschella","year":"2020","unstructured":"Camaschella C, Nai A, Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica. 2020;105:260\u201372.","journal-title":"Haematologica"},{"key":"8440_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41586-020-2668-z","volume":"586","author":"CB Billesbolle","year":"2020","unstructured":"Billesbolle CB, Azumaya CM, Kretsch RC, Powers AS, Gonen S, Schneider S, et al. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature. 2020;586:807\u201311.","journal-title":"Nature"},{"key":"8440_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","volume":"25","author":"B Galy","year":"2024","unstructured":"Galy B, Conrad M, Muckenthaler M. Mechanisms controlling cellular and systemic iron homeostasis. Nat Rev Mol Cell Biol. 2024;25:133\u201355.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8440_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-981-13-9589-5_2","volume":"1173","author":"G Gao","year":"2019","unstructured":"Gao G, Li J, Zhang Y, Chang YZ. Cellular Iron Metabolism and Regulation. Adv Exp Med Biol. 2019;1173:21\u201332.","journal-title":"Adv Exp Med Biol"},{"key":"8440_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fphar.2014.00176","volume":"5","author":"N Wilkinson","year":"2014","unstructured":"Wilkinson N, Pantopoulos K. The IRP\/IRE system in vivo: insights from mouse models. Front Pharmacol. 2014;5:176.","journal-title":"Front Pharmacol"},{"key":"8440_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10534-006-9047-6","volume":"20","author":"WH Tong","year":"2007","unstructured":"Tong WH, Rouault TA. Metabolic regulation of citrate and iron by aconitases: role of iron-sulfur cluster biogenesis. Biometals. 2007;20:549\u201364.","journal-title":"Biometals"},{"key":"8440_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/84859","volume":"27","author":"T LaVaute","year":"2001","unstructured":"LaVaute T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, et al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet. 2001;27:209\u201314.","journal-title":"Nat Genet"},{"key":"8440_CR25","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1182\/blood-2005-04-1365","volume":"106","author":"B Galy","year":"2005","unstructured":"Galy B, Ferring D, Minana B, Bell O, Janser HG, Muckenthaler M, et al. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). Blood. 2005;106:2580\u20139.","journal-title":"Blood"},{"key":"8440_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:70.","journal-title":"Signal Transduct Target Ther"},{"key":"8440_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41571-021-00539-4","volume":"18","author":"DC Singleton","year":"2021","unstructured":"Singleton DC, Macann A, Wilson WR. Therapeutic targeting of the hypoxic tumour microenvironment. Nat Rev Clin Oncol. 2021;18:751\u201372.","journal-title":"Nat Rev Clin Oncol"},{"key":"8440_CR28","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/jcb.27681","volume":"120","author":"M Najafi","year":"2019","unstructured":"Najafi M, Farhood B, Mortezaee K. Extracellular matrix (ECM) stiffness and degradation as cancer drivers. J Cell Biochem. 2019;120:2782\u201390.","journal-title":"J Cell Biochem"},{"key":"8440_CR29","doi-asserted-by":"crossref","unstructured":"Wicks EE, Semenza GL. Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Invest. 2022;132.","DOI":"10.1172\/JCI159839"},{"key":"8440_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","volume":"625","author":"D Huang","year":"2024","unstructured":"Huang D, Zhu X, Ye S, Zhang J, Liao J, Zhang N, et al. Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides. Nature. 2024;625:593\u2013602.","journal-title":"Nature"},{"key":"8440_CR31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1126\/science.adp1932","volume":"385","author":"M Tenorio","year":"2024","unstructured":"Tenorio M, Cruz-Ruiz S, Encarnacion-Guevara S, Hernandez M, Corona-Gomez JA, Sheccid-Santiago F, et al. MAYEX is an old long noncoding RNA recruited for X chromosome dosage compensation in a reptile. Science. 2024;385:1347\u201354.","journal-title":"Science"},{"key":"8440_CR32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The Role of Non-coding RNAs in Oncology. Cell. 2019;179:1033\u201355.","journal-title":"Cell"},{"key":"8440_CR33","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.3685996","volume":"238","author":"MW Hentze","year":"1987","unstructured":"Hentze MW, Caughman SW, Rouault TA, Barriocanal JG, Dancis A, Harford JB, et al. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science. 1987;238:1570\u20133.","journal-title":"Science"},{"key":"8440_CR34","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41416-023-02164-7","volume":"128","author":"EK Aglago","year":"2023","unstructured":"Aglago EK, Cross AJ, Riboli E, Fedirko V, Hughes DJ, Fournier A, et al. Dietary intake of total, heme and non-heme iron and the risk of colorectal cancer in a European prospective cohort study. Br J Cancer. 2023;128:1529\u201340.","journal-title":"Br J Cancer"},{"key":"8440_CR35","doi-asserted-by":"crossref","unstructured":"Collatuzzo G, Teglia F, Pelucchi C, Negri E, Rabkin CS, Liao LM, et al. Inverse association between dietary iron intake and gastric cancer: a pooled analysis of case-control studies of the stop consortium. Nutrients. 2022;14.","DOI":"10.3390\/nu14122555"},{"key":"8440_CR36","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/ijc.32906","volume":"147","author":"VC Chang","year":"2020","unstructured":"Chang VC, Cotterchio M, Bondy SJ, Kotsopoulos J. Iron intake, oxidative stress-related genes and breast cancer risk. Int J Cancer. 2020;147:1354\u201373.","journal-title":"Int J Cancer"},{"key":"8440_CR37","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1017\/S1368980021000471","volume":"24","author":"KY Liu","year":"2021","unstructured":"Liu KY, Feng XL, Mo XF, Lin FY, Zhang X, Huang CY, et al. Iron intake with the risk of breast cancer among Chinese women: a case-control study. Public Health Nutr. 2021;24:5743\u201355.","journal-title":"Public Health Nutr"},{"key":"8440_CR38","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41422-018-0090-y","volume":"28","author":"B Zhou","year":"2018","unstructured":"Zhou B, Zhang JY, Liu XS, Chen HZ, Ai YL, Cheng K, et al. Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis. Cell Res. 2018;28:1171\u201385.","journal-title":"Cell Res"},{"key":"8440_CR39","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1158\/1078-0432.CCR-20-3182","volume":"26","author":"J Bordini","year":"2020","unstructured":"Bordini J, Morisi F, Elia AR, Santambrogio P, Pagani A, Cucchiara V, et al. Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models. Clin Cancer Res. 2020;26:6387\u201398.","journal-title":"Clin Cancer Res"},{"key":"8440_CR40","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1021\/acsbiomaterials.0c01009","volume":"6","author":"X Liu","year":"2020","unstructured":"Liu X, Jin Y, Liu T, Yang S, Zhou M, Wang W, et al. Iron-Based Theranostic Nanoplatform for Improving Chemodynamic Therapy of Cancer. ACS Biomater Sci Eng. 2020;6:4834\u201345.","journal-title":"ACS Biomater Sci Eng"},{"key":"8440_CR41","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s10147-021-01995-9","volume":"26","author":"H Sawayama","year":"2021","unstructured":"Sawayama H, Miyamoto Y, Mima K, Kato R, Ogawa K, Hiyoshi Y, et al. Preoperative iron status is a prognosis factor for stage II and III colorectal cancer. Int J Clin Oncol. 2021;26:2037\u201345.","journal-title":"Int J Clin Oncol"},{"key":"8440_CR42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/jso.22032","volume":"105","author":"L Zhen","year":"2012","unstructured":"Zhen L, Zhe S, Zhenning W, Zhifeng M, Zhidong L, Xiaoxia L, et al. Iron-deficiency anemia: a predictor of diminished disease-free survival of T3N0M0 stage colon cancer. J Surg Oncol. 2012;105:371\u20135.","journal-title":"J Surg Oncol"},{"key":"8440_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12957-015-0488-7","volume":"13","author":"MS An","year":"2015","unstructured":"An MS, Yoo JH, Kim KH, Bae KB, Choi CS, Hwang JW, et al. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy. World J Surg Oncol. 2015;13:64.","journal-title":"World J Surg Oncol"},{"key":"8440_CR44","doi-asserted-by":"publisher","first-page":"927787","DOI":"10.3389\/fsurg.2022.927787","volume":"9","author":"T Jiang","year":"2022","unstructured":"Jiang T, Liu K, Chen Z. The impact of perioperative red blood cell transfusion on the prognosis of colorectal cancer. Front Surg. 2022;9:927787.","journal-title":"Front Surg"},{"key":"8440_CR45","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.surg.2021.02.003","volume":"170","author":"J Zuckerman","year":"2021","unstructured":"Zuckerman J, Coburn N, Callum J, Mahar AL, Acuna SA, Guttman MP, et al. Association of perioperative red blood cell transfusions with all-cause and cancer-specific death in patients undergoing surgery for gastrointestinal cancer: Long-term outcomes from a population-based cohort. Surgery. 2021;170:870\u20139.","journal-title":"Surgery"},{"key":"8440_CR46","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/ijc.32917","volume":"146","author":"MW Schoen","year":"2020","unstructured":"Schoen MW, Hoque S, Witherspoon BJ, Schooley B, Sartor O, Yang YT, et al. End of an era for erythropoiesis-stimulating agents in oncology. Int J Cancer. 2020;146:2829\u201335.","journal-title":"Int J Cancer"},{"key":"8440_CR47","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1038\/s41467-023-43974-w","volume":"14","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Huang C, Zhang C, Zhou Y, Zhao E, Zhang Y, et al. LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation. Nat Commun. 2023;14:8141.","journal-title":"Nat Commun"},{"key":"8440_CR48","doi-asserted-by":"publisher","first-page":"e2300314","DOI":"10.1002\/advs.202300314","volume":"10","author":"H Pei","year":"2023","unstructured":"Pei H, Dai Y, Yu Y, Tang J, Cao Z, Zhang Y, et al. The Tumorigenic Effect of lncRNA AFAP1-AS1 is Mediated by Translated Peptide ATMLP Under the Control of m(6) A Methylation. Adv Sci (Weinh). 2023;10:e2300314.","journal-title":"Adv Sci (Weinh)"},{"key":"8440_CR49","doi-asserted-by":"crossref","unstructured":"Mayank AK, Pandey V, Vashisht AA, Barshop WD, Rayatpisheh S, Sharma T, et al. An oxygen-dependent interaction between FBXL5 and the CIA-targeting complex regulates iron homeostasis. Mol Cell. 2019;75:382\u201393 e5.","DOI":"10.1016\/j.molcel.2019.05.020"},{"key":"8440_CR50","doi-asserted-by":"publisher","first-page":"e114760","DOI":"10.15252\/embj.2023114760","volume":"42","author":"A Sparmann","year":"2023","unstructured":"Sparmann A, Vogel J. RNA-based medicine: from molecular mechanisms to therapy. EMBO J. 2023;42:e114760.","journal-title":"EMBO J"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08440-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08440-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08440-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T07:49:00Z","timestamp":1788162540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08440-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8440"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08440-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All human tissue experiments were performed in accordance with the relevant guidelines and regulations of the Ethics Committee of Tianjin Medical University Cancer Institute and Hospital (Approval number: Ek2021345). All animal experimental procedures were performed in accordance with protocols approved by the Institutional Animal Care and Research Advisory Committee of Tianjin Medical University Cancer Institute and Hospital (Approval number: AE- 2021025).","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1120"}}